Financhill
Back

Design Therapeutics Quote, Financials, Valuation and Earnings

Design Therapeutics Price Quote

$5.61
+0.01 (+-8.63%)
(Updated: December 14, 2024 at 5:30 AM ET)

Design Therapeutics Key Stats

Sell
39
Design Therapeutics (DSGN) is a Sell

Day range:
$5.16 - $6.16
52-week range:
$2.25 - $7.77
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.26%

Volume:
281.4K
Avg. volume:
167.9K
1-year change:
118.75%
Market cap:
$317.1M
Revenue:
$0
EPS:
$-0.85

How Much Does Design Therapeutics Make?

Data Unavailable

Is Design Therapeutics Growing As A Company?

Data Unavailable

Design Therapeutics Stock Price Performance

What Is Design Therapeutics 52-Week High & Low?

Design Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Design Therapeutics?

Is Design Therapeutics Cash Flow Positive?

  • What Is DSGN Cash Flow From Operations?
    Cash flow from operations (TTM) is -$46M
  • What Is Design Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $751K
  • What Is Design Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $47.7M

Design Therapeutics Return On Invested Capital

Data Unavailable

Design Therapeutics Earnings Date & Stock Price

Design Therapeutics Competitors

Design Therapeutics Dividend Yield

Design Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 5.48%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 7.00
Upside from Last Price: 25%

Major Shareholders

  • How many DSGN shares are owned by institutional investors?
    35.9M DSGN shares are owned by institutional investors
  • How many DSGN shares are owned by insiders?
    1.2M DSGN shares are owned by insiders